Filter by:
Revita
EASL, April 2016.
Endoscopic Duodenal Mucosal Resurfacing (DMR) Improves Metabolic Measures, Including Hepatic Transaminase Levels, in Patients with Type 2 Diabetes: Data from a First-in-Human Study
Rajagopalan, et al. presented at The International Liver Congress-European Association for the Study of the Liver (EASL). Barcelona, Spain, April 2016.
Revita
DDW, May 2016.
Endoscopic Duodenal Mucosal Resurfacing (DMR) Improves Glycemic and Hepatic Parameters in Patients with Type 2 Diabetes: Data from a First-in-Human Study
Rajagopalan, et al. presented at Digestive Disease Week (DDW). San Diego, Calif, USA, May 2016.
Revita
WCIRS, December 2015.
Early clinical experience of duodenal mucosal resurfacing (DMR), a new endoscopic approach to treating type 2 diabetes
Cherrington, et al. presented poster at 13th World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRS). Los Angeles, Calif., USA, December 2015.
Revita
WCITT2D, September 2015.
Duodenal mucosal resurfacing (DMR) as a new endoscopic treatment for type 2 diabetes (T2D): Safety and proof-of principle cohort study
Cherrington, et al. presented poster at Third World Congress on Interventional Therapies for Type 2 Diabetes (WCITT2D). London, UK, September 2015.
Revita
EASD, September 2014.
Evaluation of the Duodenal Mucosal Resurfacing (DMR) for the Treatment of Type 2 Diabetes
Holleman. presented at 50th Annual Meeting of the European Association for the Study of Diabetes (EASD). Vienna, Austria, September 2014.
Revita
EASD, September 2014.
Metabolic Surgery for Type 2 Diabetes – Window into Pathophysiology
Rubino. presented at 50th Annual Meeting of the European Association for the Study of Diabetes (EASD). Vienna, Austria, September 2014.
Revita
UEGW, October 2015.
Duodenal mucosal resurfacing (DMR) as a new endoscopic treatment for type 2 diabetes (T2D): Safety and proof-of principle cohort study
Cherrington, et al. presented poster at United European Gastroenterology Week (UEGW). Barcelona, Spain, October 2015.
Revita
IFSO, August 2014.
Duodenal Mucosal Resurfacing A New Procedural Therapy for Type 2 Diabetes
Galvao, et al. presented at World Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). Montreal, Canada, August 2014.